21-Mar-2026
Download PDF
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Launches GLIPIQ (Semaglutide) in India. Setting a new benchmark in affordability for GLP-1 therapy with weekly treatment starting at Rs. 325
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
